GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Jyothy Labs Ltd

Jyothy Labs: Pril and Fa Brand License Agreements Not Renewed by Henkel

BOARD ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 09 May 2026, 03:28 PM IST  ·  BSE ID: eb52776f-67cf-4953-8f40-8d91536509ef
View Original BSE Filing (PDF)
💡
In Simple Terms
Jyothy Labs will stop selling Pril and Fa brands after May 31, 2026, as the license agreement with Henkel is not renewed.
🤖 AI Summary
  • License agreements with Henkel for Pril and Fa brands not renewed beyond May 31, 2026.
  • Agreements for manufacturing, distribution, marketing, and sale in place since May 31, 2011.
  • Henkel AG & Co. KGaA decided against renewal, effective post May 31, 2026.
  • Jyothy Labs' board meeting concluded no further reasonable renewal possibility.
  • Financial impact is currently under evaluation by Jyothy Labs.
🏢 How This Affects the Company
📈
Business Impact
The non-renewal means Jyothy Labs will cease manufacturing, distributing, marketing, and selling the Pril and Fa brands after May 31, 2026, impacting its product portfolio and market presence in these categories. This requires a strategy to either replace or compensate for the associated revenue streams.
💰
Financial Impact
The financial impact, including on revenue and profitability from the Pril and Fa brands, is currently under evaluation by the company. The agreements contained processes for business valuation and transfer mechanisms in the event of discontinuation.
⚙️
Operational Impact
Operations related to the manufacturing, distribution, and marketing of Pril and Fa brands will be discontinued post-May 31, 2026, requiring adjustments to production schedules, supply chain, and marketing efforts.
⚠️
Risk Impact
This introduces a new business risk related to potential revenue loss from the discontinuation of these brands and the need to mitigate this impact through new product introductions or portfolio adjustments. The company is evaluating all available options.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as the company's business portfolio changes, and the financial impact from the discontinuation of Pril and Fa brands is yet to be quantified.
🔍
Management Signal
Management is actively evaluating all options available to the company following the non-renewal of the Pril and Fa brand licenses.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Jyothy Labs' upcoming quarterly results — watch for specifics on Pril and Fa brand contribution.
Company disclosures on the financial impact of the license non-renewal.
Announcements regarding new strategies or product introductions to mitigate impact.
MEDIUM RISK The non-renewal of key brand licenses poses a business and financial impact that is currently under evaluation.
💡 Investor Takeaway
Jyothy Labs will discontinue its manufacturing, distribution, marketing, and sale of Pril and Fa brands after May 31, 2026, as license agreements with Henkel will not be renewed. The financial impact is under current evaluation by the company.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Cessation of manufacturing, distribution, marketing, and sale of Pril and Fa brands after May 31, 2026.
  • The financial impact of this discontinuation on the company's performance is currently under evaluation.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.